Showing results (21-30 of 143) with videos related to
Sort By:
Pageof 15
Cancer Biology & Therapy|March 22, 2007
Proteasome inhibition specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteinsArnaud Pigneux, François-Xavier Mahon, François Moreau-Gaudry, et al.Leukemia Research|December 17, 2011
Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot seriesPatrice Chevallier, Arnaud Pigneux, Nelly Robillard, et al.Cancer|September 24, 2005
Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatmentDidier P Blaise, Jean Michel Boiron, Catherine Faucher, et al.Journal of Hematology|November 23, 2020
Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective AnalysisNathan Mottal, Nahema Issa, Pierre-Yves Dumas, et al.Ejhaem|January 29, 2025
Relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia responds well to a combination of modified hyper-CVAD, blinatumomab and tyrosine kinase inhibitorGaétan Basile, Jean Galtier, Titouan Cazaubiel, et al.International Journal of Clinical Pharmacy|July 12, 2011
Induction-related cost of patients with acute myeloid leukaemia in FranceVirginie Nerich, Bruno Lioure, Maryline Rave, et al.British Journal of Haematology|February 2, 2026
Optical genome mapping detects cryptic high-risk and targetable abnormalities in adult AMLAudrey Bidet, Elodie Laharanne, Manon Dos Santos, et al.British Journal of Haematology|May 7, 2022
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapseLuc Heraudet, Jean Galtier, Simon Favre, et al.Leukemia Research Reports|July 29, 2014
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromesStuart L Goldberg, Pierre Fenaux, Michael D Craig, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Methotrexate Reduces the Incidence of Severe Acute Graft-versus-Host Disease without Increasing the Risk of Relapse after Reduced-Intensity Allogeneic Stem Cell Transplantation from Unrelated DonorsStéphane Vigouroux, Reza Tabrizi, Cyril Melot, et al.Pageof 15